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PHARMACOPOEIA 
MONOGRAPHS 
INTRODUCTION 
 
 
• Pharmacopoeia, pharmacopeia, or pharmacopoea (literally, 
"drug-making"), in its modern technical sense, is a book 
containing directions for the identification of compound 
medicines, and published by the authority of a government or a 
medical or pharmaceutical society. Descriptions of 
preparations are called monographs. 
 
• Monographs are based on the specifications for 
substances used in medicinal products approved in 
Member States. When a monograph is added to the work 
programme, enquiries are made by the EDQM to identify 
manufacturers of such substances and all data received is 
taken into account for preparation of the monograph. 
Interested parties should be invited to participate in the 
elaboration of the monograph before publication in 
Pharmeuropa, since the 3-month public period will often 
be too short for all interested parties to check the draft 
monograph. 
• Prior to the preparation of any monograph, it is essential to 
gather as much information as possible on the substance in 
question. 
In particular it is necessary to ascertain: 
•  whether the substance is of natural, synthetic or semi-
synthetic origin; 
•  whether the substance is a mixture or a single entity; 
•  the method(s) of preparation in detail; 
•  whether there are different crystalline forms, since the 
properties of the substance may vary in accordance with this 
parameter 
• whether both an enantiomer as well as the racemate or other 
mixtures of enantiomers are available; 
•  whether different hydrates are available; 
•  whether different entities (acid, base, salt, etc) are available 
• The Pharmacopoeia and other relevant documents on the 
state of work must be consulted to see if monographs on 
similar substances exist or are being elaborated.  
• If monographs or draftson similar substances already 
exist, it is important to ensure that the monograph to be 
elaborated follows the same approach unless there are 
good reasons to deviate, e.g. developments in analytical 
techniques. 
• Substances that are to be described in a monograph may 
be members of a group of very similar substances 
(family). This holds true especially for excipients such as 
macrogols. 
TITLE 
• The International Nonproprietary Name (INN) established by the 
World Health Organization should be used wherever it is available; it 
is supplemented as appropriate by the name of the anion or cation 
and by “hydrate”, “dihydrate”, “hydrated” (for ill-defined degrees of 
hydration) or “anhydrous” (where a hydrated form is also known to 
exist).  
• Formerly, the degree of hydration was not indicated in titles unless 2 
forms were known to be available; 
• existing titles of this type are not changed on revision unless it is 
known that 2 forms are available or if there is a public health 
imperative (for example, high water content that could lead to errors 
in formulation).  
• Anions and cations are indicated as “mono-”, “di-”, “tri-”, etc., as 
appropriate. 
• Where a substance is used in approved medicinal products for 
veterinary use only in Member States, “for veterinary use” is 
included in the title. 
DEFINITION 
• The chemical structure must be ascertained with the greatest possible 
precision in order to establish the exact: 
•  graphic formula; 
•  empirical formula and relative molecular mass 
• chemical name 
-This implies investigating in particular: 
• the possible existence of isomers so as to be able to specify which 
isomer is used or, otherwise, to state that the product is a mixture of 
isomers; 
• in the case of an optical isomer, it is insufficient to take into account 
only the direction of the optical rotation. The absolute configuration 
is given by the R/S system at the asymmetrical centre(s) or any other 
appropriate system (e.g., for carbohydrates and amino acids); 
•  ascertaining the state of hydration or solvation so as to distinguish 
clearly between the well-defined hydrates and solvates and the 
products that contain variable quantities of solvent(s). 
COMBINATIONS 
• In therapeutics, more or less well-defined chemical 
combinations (for instance, theophyllineethylenediamine) 
or even mixtures are sometimes used. 
•  In such cases, it is necessary to specify precisely each 
component of the combination or mixture, with its 
chemical structure and the proportion in which it is 
present. 
CONTENT 
• The substance described by a monograph is never a wholly 
pure substance but contains a limited proportion of impurities. 
The content is therefore an important part of the definition. 
• Assay limits are specified between which the content must fall.  
• The assay limits must take account of the precision of the 
method as well as the acceptable purity of the substance. Assay 
limits are normally expressed with reference to the dried or 
anhydrous substance 
• For a non-specific assay (for example, titrimetry) the assay 
limits are usually 99.0-101.0 % (unless otherwise justified). 
•  For a specific assay using a separation technique (for example, 
liquid or gas chromatography), the upper assay limit is 
normally 102.0 %; the lower assay limit will take any 
necessary account of the impurities present and may therefore 
be lower than 98.0 %. 
CHARACTERS 
1. APPEARANCE  
This description will normally embrace color and physical form. 
2. TASTE  
The taste is not to be taken into consideration 
3. ODOUR 
In general, no reference is made to odor 
4. SOLUBILITY 
• Solvents quoted are normally confined to water, an alcohol and a 
lipophilic solvent. Solubility in chloroform and ether are not 
mentioned. In special cases the solubility of different samples of a 
material may vary rather considerably even though their composition 
is still within the limits set by the monograph. The solubilities in the 
solvents thereby affected are then given to cover more than one 
solubility class, e.g. “sparingly soluble to soluble in...”. The solubility 
or miscibility in other solvents with which the material is often 
combined in practice such as fatty oils, etc., may also be mentioned. 
CHARACTERS 
5. Stability factors 
• Evidence of instability due to exposure to air, light and 
for moisture is to be given, e.g. physostigmine sulfate  
turns red when exposed to air and light.  
6. Hygroscopicity  
• A pragmatic method recommended for the determination 
of the tendency of a substance to take up atmospheric 
water 
• Some substances are hygroscopic or deliquescent, which 
results in difficulties for the analyst during weighing 
procedure 
 
CHARACTERS 
7. Solid-state properties 
• Solid-state properties include crystallinity, polymorphism, 
density of solids, particle size of solids and specific surface 
area of solids. Solid-state properties, particularly 
polymorphism and pseudopolymorphism, may have an effect 
on the bioavailability of the substance and for the production 
of the medicinal product 
• Two cases are to be distinguished when polymorphism is 
known to exist: 
•  usually, the monograph does not exclude any of the possible 
crystalline forms; 
•  exceptionally, if the substance is only used in solid dosage 
forms and one form has been shown to be preferred from the 
point of view of bioavailability or to have a better 
safety/efficacy profile, then the monograph may be limited to 
that form. 
CHARACTERS 
8. Other characteristics 
• -Melting point (insufficiently precise to allow a range 
to be quoted) 
• When decomposition may occur, this must be stated.  
• Other general characteristics that may be of relevance for 
quotation include an indication of direction of optical rotation 
in a particular solvent or, in the case of radioactive materials, a 
note of the half-life of the radionuclide defined and of the type 
of radiation that it emits. 
9. Behavior in solution 
• In cases where it is known that rapid degradation 
may occur in solution, this information is given as a 
warning statement.  
 
IDENTIFICATION 
• The purpose of the IDENTIFICATION section of a monograph 
is to provide confirmation of the identity of the substance in 
question. Identification according to the Pharmacopoeia is thus 
generally of a much more limited scope than the structural 
elucidation of an unknown substance or the determination of 
the composition of an unknown mixture.  
• The task of identifying a material is not to be confused with the 
assessment of its purity or the determination of its strength, 
although ultimately all 3 aspects are complementary. 
• It follows from the above that the physical and/or chemical 
tests and reactions, when taken together, that enter into the  
IDENTIFICATION section ensure, as far as possible, 
specificity.  
• The specificity of the identification should be such that active 
substances and excipients exhibiting similar structures are 
distinguished. 
IDENTIFICATION 
Methods requiring complex instrumentation 
•  Spectrophotometric analysis, such as recording of infrared or nuclear  
magnetic resonance spectra. 
• Chromatographic examination by means of gas chromatography 
(GC) or liquid chromatography (LC). 
Other methods 
• Determination of physical constants such as melting point, freezing 
point, boiling point, specific optical rotation, angle of rotation, 
ultraviolet spectrum, specific absorbance, relative density, refractive 
index and viscosity. 
• Chemical reactions such as color or precipitation reactions (including 
formation of derivatives or degradation products, which may 
subsequently be subjected to physical examination) and 
determination of chemical values (saponification, ester, hydroxyl and 
iodine values). 
• Chromatographic examination by thin-layer chromatography (TLC). 
TESTS 
Solution S 
• A solution of the substance to be examined, designated “Solution S”, is prepared 
whenever this can be used to perform more than one test (and/or identification). 
• If necessary, several solutions S, (designated S1, S2...) may be prepared in various 
ways, each being used for at least 2 tests. 
• For insoluble substances, solution S may be prepared by an extraction process. 
• The solvent used depends on the solubility of the substance to be examined and that of 
its potential impurities. It may be: 
• water (usually): 
• o carbon dioxide-free water in cases where the presence of carbon dioxide can 
appreciably influence the outcome of a test, e.g. for pH or Acidity or alkalinity 
o distilled water if solution S is used in the tests for barium, calcium and sulfates; 
• o carbon dioxide-free water prepared from distilled water when both aforementioned 
considerations apply; 
• a dilute acid or an alkaline solution; 
• more rarely, other solvents (alcohols, tetrahydrofuran...) that give solutions with a 
narrower field of application than aqueous solutions. 
 
TESTS 
Solution S 
• The solvent used and the concentration chosen depend on the solubility of the 
substance to be examined and the purpose for which the test is intended. The solvent 
must make it possible to carry out the specified tests, either directly, or after suitable 
dilutions explicitly specified in each test.  
• Generally the concentration is around 20 to 50 g/L but may be lower (e.g. 10 g/L) or 
higher (100 g/L and, exceptionally, more). The quantity of solution S prepared must be 
sufficient to carry out each of the tests for which it has been prepared. If solution S is 
to be filtered, account must be taken of the loss on filtering and when the insoluble 
portion thus separated is to be used for another test, this is clearly indicated. 
• If several tests can be carried out on the same portion of solution S, this is only done 
for substances where there are good reasons to economise (expensive products or 
products whose use is subject to restrictions) and this is then clearly indicated in the 
monograph. 
TESTS 
Solution S 
• Depending on the particular tests, the concentration of solution S is defined 
with varying precision: 
• for “Appearance of solution”, “pH” and some identifications, a precision of 5 
to 10 % is sufficient; 
• for most limit tests a precision of about 2 % is appropriate; 
• for some cases such as the determination of specific rotation, specific 
absorbance, various chemical values and, more generally, tests where the 
result is obtained by calculation, a greater precision is needed. 
TESTS 
Solution S 
• The precision with which the concentration of solution S is defined is that 
required by the most exacting test for which it is intended. 
• The description of the preparation of solution S thus specifies: 
•  the quantity of substance to be examined with the required precision  
•  the volume, to 1 decimal place (10.0 mL, 25.0 mL...) when the 
concentration must be known to within less than 1 %, without a decimal (10 
mL, 25 mL...) when a lower precision is adequate. 
TESTS 
Appearance of solution 
• This test makes it possible to ascertain the general purity of a substance by 
the detection of impurities insoluble in the solvent selected, or of coloured 
impurities. 
• The “Appearance of solution” test is practically always prescribed for 
substances intended for preparations for parenteral use. Apart from this, it is 
to be applied only if it yields useful information concerning the general 
purity of the substance. 
• It can comprise both tests or one only, namely: 
•  clarity and degree of opalescence of liquids 
•  degree of coloration of liquids 
TESTS 
Appearance of solution 
• The 2 tests are practically always carried out on identical solutions, usually 
solution S, but they may be performed on different solutions. 
• The solvent employed is usually water but other solvents may be preferred 
depending on the solubility of the substance to be examined. 
• When an organic solvent is used to prepare solution S, it may be necessary to 
ensure that the solvent also complies with the test, especially where there is a 
very stringent requirement. 
• The more concentrated the solution the stricter the test. For very pure 
substances or those used in high doses, the concentration chosen is 50 to 100 
g/L, whereas for less pure substances or substances administered in small 
doses the concentration is 10 to 20 g/L. 

